CA
AIFF

Continuum Advisory’s Firefly Neuroscience AIFF Stock Holding History

Continuum Advisory’s Portfolio AIFF Stock Details AIFF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$4 – 1646
2025
Q1 		$4 Hold
1
– – ﹤0.01% 1657
2024
Q4 		$3 Sell
1
-22
-96% -$68 ﹤0.01% 1852
2024
Q3 		$73 Buy
+23
New +$121 ﹤0.01% 1886
2024
Q2 		– Hold
0
– – – 1703
2024
Q1 		– Hold
0
– – – 1698

Other funds holding AIFF

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WPW
Waldron Private Wealth Bridgeville, Pennsylvania $2.89B AUM 23.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Continuum Advisory's AIFF Position: Q2 2025 in Review

Continuum Advisory sold out of Firefly Neuroscience (AIFF) in Q2 2025, closing a stake of 1 share — an estimated $4 sold.

Continuum Advisory first reported a position in AIFF in Q3 2024 and held it in 3 quarters. The position peaked at $73 in Q3 2024. 23 funds tracked by Wall St. Rank hold AIFF as of Q2 2025.

  • Continuum Advisory reported no remaining Firefly Neuroscience position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 1 Firefly Neuroscience share in Q2 2025, an estimated $4.
  • Continuum Advisory first reported a position in Firefly Neuroscience in Q3 2024 and held it in 3 quarters.
  • Continuum Advisory's Firefly Neuroscience position peaked at $73 in Q3 2024.
  • 23 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.